Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer. A Randomized, Placebo Controlled Clinical Trial

NCT03400709 is registered in ClinicalTrials.gov with Hospital San Juan de Dios, Santiago as lead sponsor.

NCT NCT03400709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03400709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer. A Randomized, Placebo Controlled Clinical Trial
Lead sponsor
Hospital San Juan de Dios, Santiago
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
November 30, 2017
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cisplatin adverse reaction, hearing loss ototoxic